Hashimoto's Encephalopathy: an Endocrinological Point of View

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Apr 26

PMID 38665262

Authors

Laura Croce

Marzia Dal Molin

Marsida Teliti

Mario Rotondi

Affiliations

Soon will be listed here.

References

Mahad D, Staugaitis S, Ruggieri P, Parisi J, Kleinschmidt-DeMasters B, Lassmann H . Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci. 2004; 228(1):3-5. DOI: 10.1016/j.jns.2004.08.015. View

Cook M, Malkin M, Karafin M . The use of plasma exchange in Hashimoto's encephalopathy: A case report and review of the literature. J Clin Apher. 2014; 30(3):188-92. DOI: 10.1002/jca.21353. View

Gastaldi M, Mariotto S, Giannoccaro M, Iorio R, Zoccarato M, Nosadini M . Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study. Eur J Neurol. 2019; 27(4):633-643. DOI: 10.1111/ene.14139. View

Waliszewska-Prosol M, Bladowska J, Budrewicz S, Sasiadek M, Dziadkowiak E, Ejma M . The evaluation of Hashimoto's thyroiditis with event-related potentials and magnetic resonance spectroscopy and its relation to cognitive function. Sci Rep. 2021; 11(1):2480. PMC: 7843607. DOI: 10.1038/s41598-021-82281-6. View

Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H . Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy. J Neuroimmunol. 2005; 162(1-2):130-6. DOI: 10.1016/j.jneuroim.2005.02.004. View

Hayashi Y, Yamada M, Kimura A, Asano T, Satoh K, Kitamoto T . Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of α-enolase. Prion. 2017; 11(6):454-464. PMC: 5786357. DOI: 10.1080/19336896.2017.1377876. View

Okitsu M, Sugaya K, Yoneda M, Takahashi K . Hashimoto Encephalopathy Presenting with Acute Psychosis and Inappropriate Secretion of Antidiuretic Hormone: A Rare Case Responding to Steroid Therapy. Am J Case Rep. 2023; 24:e942297. PMC: 10728882. DOI: 10.12659/AJCR.942297. View

Ishii K, Hayashi A, Tamaoka A, Usuki S, Mizusawa H, Shoji S . Case report: thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto's encephalopathy. Am J Med Sci. 1995; 310(5):202-5. DOI: 10.1097/00000441-199511000-00005. View

Mocellin R, Walterfang M, Velakoulis D . Hashimoto's encephalopathy : epidemiology, pathogenesis and management. CNS Drugs. 2007; 21(10):799-811. DOI: 10.2165/00023210-200721100-00002. View

10.

Olmez I, Moses H, Sriram S, Kirshner H, Lagrange A, Pawate S . Diagnostic and therapeutic aspects of Hashimoto's encephalopathy. J Neurol Sci. 2013; 331(1-2):67-71. DOI: 10.1016/j.jns.2013.05.009. View

11.

Endres D, Dersch R, Hochstuhl B, Fiebich B, Hottenrott T, Perlov E . Intrathecal Thyroid Autoantibody Synthesis in a Subgroup of Patients With Schizophreniform Syndromes. J Neuropsychiatry Clin Neurosci. 2017; 29(4):365-374. DOI: 10.1176/appi.neuropsych.16110296. View

12.

Shaw P, Walls T, Newman P, Cleland P, Cartlidge N . Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases. Neurology. 1991; 41(2 ( Pt 1)):228-33. DOI: 10.1212/wnl.41.2_part_1.228. View

13.

Hollowell J, Staehling N, Flanders W, Hannon W, Gunter E, Spencer C . Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87(2):489-99. DOI: 10.1210/jcem.87.2.8182. View

14.

Sorodoc V, Constantin M, Asaftei A, Lionte C, Ceasovschih A, Sirbu O . The use of intravenous immunoglobulin in the treatment of Hashimoto's encephalopathy: case based review. Front Neurol. 2023; 14:1243787. PMC: 10513043. DOI: 10.3389/fneur.2023.1243787. View

15.

Chong J, Rowland L, Utiger R . Hashimoto encephalopathy: syndrome or myth?. Arch Neurol. 2003; 60(2):164-71. DOI: 10.1001/archneur.60.2.164. View

16.

Smets I, Titulaer M . Antibody Therapies in Autoimmune Encephalitis. Neurotherapeutics. 2022; 19(3):823-831. PMC: 8775146. DOI: 10.1007/s13311-021-01178-4. View

17.

Mattozzi S, Sabater L, Escudero D, Arino H, Armangue T, Simabukuro M . Hashimoto encephalopathy in the 21st century. Neurology. 2019; 94(2):e217-e224. DOI: 10.1212/WNL.0000000000008785. View

18.

Waliszewska-Prosol M, Ejma M . Assessment of Visual and Brainstem Auditory Evoked Potentials in Patients with Hashimoto's Thyroiditis. J Immunol Res. 2021; 2021:3258942. PMC: 7946475. DOI: 10.1155/2021/3258942. View

19.

Chaudhuri J, Mukherjee A, Chakravarty A . Hashimoto's Encephalopathy: Case Series and Literature Review. Curr Neurol Neurosci Rep. 2023; 23(4):167-175. PMC: 9972331. DOI: 10.1007/s11910-023-01255-5. View

20.

Sechi E, Flanagan E . Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front Neurol. 2021; 12:673339. PMC: 8292678. DOI: 10.3389/fneur.2021.673339. View